Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma. Derenzini E, Tabanelli V, Sammassimo S, Mazzara S, et al. Bone Marrow Transplant 2021 May 7. pii: 10.1038/s41409-021-01320.

Read + Share

Amedeo Smart

Independent Medical Education

Derenzini E, Tabanelli V, Sammassimo S, Mazzara S, et al. Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma. Bone Marrow Transplant 2021 May 7. pii: 10.1038/s41409-021-01320.
PMID: 33963303